Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Occupational Safety and Health Training Projects Grants, Request for Applications (RFA) 06-484; Occupational Safety and Health Educational Research Centers, RFA 06-485, 60296 [E8-23809]

Download as PDF 60296 Federal Register / Vol. 73, No. 198 / Friday, October 10, 2008 / Notices Dated: October 1, 2008. Antonia T. Harris, Deputy Assistant Secretary for Human Resources,Department of Health and Human Services. [FR Doc. E8–23796 Filed 10–9–08; 8:45 am] BILLING CODE 5150–04–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on PROD1PC66 with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Occupational Safety and Health Training Projects Grants, Request for Applications (RFA) 06– 484; Occupational Safety and Health Educational Research Centers, RFA 06–485 In accordance with section 10(a)(2) of the Federal AdvisoryCommittee Act (Pub. L. 92–463), the Centers for DiseaseControl and Prevention (CDC) announces the aforementioned meeting: Times and Dates:8:30 a.m.–5 p.m., December 11, 2008 (Closed).8:30 a.m.–5 p.m., December 12, 2008 (Closed). Place: Harbour View Inn, 2 Vendue Range, Charleston, South Carolina 29401, Telephone (843) 853–8439. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Occupational Safety and Health Training Projects Grants, RFA 06–484; Occupational Safety and Health Educational Research Centers, RFA 06– 485.’’ There will be a site visit at the University of California, Los Angeles (UCLA), on November 11–13, 2008; to advise and make recommendations to the Disease, Disability, and Injury Prevention and Control SEP: Occupational Safety and Health Training Projects Grants, RFA 06–484; Occupational Safety and Health Educational Research Centers, RFA 06– 485. Times, Dates, and Place of site visit: Times and Dates:7 a.m.–9 p.m., November 11, 2008.8 a.m.–6:30 p.m., November 12, 2008.8 a.m.–5 p.m., November 13, 2008. Place: UCLA Guest House, 330 Charles E. Young Drive East, Los Angeles, California 90095. VerDate Aug<31>2005 20:11 Oct 09, 2008 Jkt 217001 Contact Person for More Information: Dr. M. Chris Langub, Ph.D., Scientific Review Administrator, 1600 Clifton Road NE., Mailstop E74, Atlanta, GA 30333, telephone (404) 498–2543. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: October 1, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–23809 Filed 10–9–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–R–262, CMS– 10142, CMS–10175 and CMS–R–218] Agency Information Collection Activities: Proposed Collection; Comment Request Agency: Centers for Medicare & Medicaid Services. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS) is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: CY 2010 Plan Benefit Package (PBP) and Formulary Submission for Medicare Advantage (MA) Plans and Prescription Drug Plans (PDP) Use: Under the Medicare Modernization Act (MMA), Medicare Advantage (MA) and Prescription Drug PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 Plan (PDP) organizations are required to submit plan benefit packages for all Medicare beneficiaries residing in their service area. The plan benefit package submission consists of the formulary file, Plan Benefit Package (PBP) software, and supporting documentation as necessary. MA and PDP organizations will generate a formulary to illustrate their list of drugs, including information on prior authorization, step therapy, tiering, and quantity limits. Additionally, the PBP software will be used to describe their organization’s plan benefit packages, including information on premiums, cost sharing, authorization rules, and supplemental benefits. CMS uses the formulary and PBP data to review and approve the plan benefit packages proposed by each MA and PDP organization. CMS requires that MA and PDP organizations submit a completed formulary and PBP as part of the annual bidding process. During this process, organizations prepare their proposed plan benefit packages for the upcoming contract year and submit them to CMS for review and approval. Based on operational changes and policy clarifications to the Medicare program and continued input and feedback by the industry, CMS has made the necessary changes to the plan benefit package submission. Form Number: CMS–R–262 (OMB# 0938–0763); Frequency: Yearly; Affected Public: Business or other for-profits b. Not-forprofit institutions; Number of Respondents: 475; Total Annual Responses: 4987.5; Total Annual Hours: 12112.5. 2. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: CY 2010 Bid Pricing Tool (BPT) for Medicare Advantage (MA) Plans and Prescription Drug Plans (PDP). Use: Under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA), and implementing regulations at 42 CFR, Medicare Advantage organizations (MAO) and Prescription Drug Plans (PDP) are required to submit an actuarial pricing ‘‘bid’’ for each plan offered to Medicare beneficiaries for approval by CMS. MAOs and PDPs use the Bid Pricing Tool (BPT) software to develop their actuarial pricing bid. The information provided in the BPT is the basis for the plan’s enrollee premiums and CMS payments for each contract year. The tool collects data such as medical expense development (from claims data and/or manual rating), administrative expenses, profit levels, and projected plan enrollment information. By statute, E:\FR\FM\10OCN1.SGM 10OCN1

Agencies

[Federal Register Volume 73, Number 198 (Friday, October 10, 2008)]
[Notices]
[Page 60296]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-23809]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Occupational Safety and Health Training Projects 
Grants, Request for Applications (RFA) 06-484; Occupational Safety and 
Health Educational Research Centers, RFA 06-485

    In accordance with section 10(a)(2) of the Federal 
AdvisoryCommittee Act (Pub. L. 92-463), the Centers for DiseaseControl 
and Prevention (CDC) announces the aforementioned meeting:
    Times and Dates:8:30 a.m.-5 p.m., December 11, 2008 (Closed).8:30 
a.m.-5 p.m., December 12, 2008 (Closed).
    Place: Harbour View Inn, 2 Vendue Range, Charleston, South Carolina 
29401, Telephone (843) 853-8439.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Occupational Safety and Health Training 
Projects Grants, RFA 06-484; Occupational Safety and Health Educational 
Research Centers, RFA 06-485.''
    There will be a site visit at the University of California, Los 
Angeles (UCLA), on November 11-13, 2008; to advise and make 
recommendations to the Disease, Disability, and Injury Prevention and 
Control SEP: Occupational Safety and Health Training Projects Grants, 
RFA 06-484; Occupational Safety and Health Educational Research 
Centers, RFA 06-485.
    Times, Dates, and Place of site visit:
    Times and Dates:7 a.m.-9 p.m., November 11, 2008.8 a.m.-6:30 p.m., 
November 12, 2008.8 a.m.-5 p.m., November 13, 2008.
    Place: UCLA Guest House, 330 Charles E. Young Drive East, Los 
Angeles, California 90095.
    Contact Person for More Information: Dr. M. Chris Langub, Ph.D., 
Scientific Review Administrator, 1600 Clifton Road NE., Mailstop E74, 
Atlanta, GA 30333, telephone (404) 498-2543.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: October 1, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E8-23809 Filed 10-9-08; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.